Key Market Indicators
Sales of Korean analgesic medicine are projected to reach $501.61 million by 2026. This is up 2% annually from 2021's $450.34 million. Since 2013, the Korean market has grown by an average of 6.5% each year. In 2021, Korea came in fifth place, behind Italy at $450.34 million. Spain, Canada, and Italy followed in second, third and fourth place respectively.